A solid positive breakout is seen in these stocks; do you hold them?
A solid positive breakout is seen in these stocks; do you hold them?

A solid positive breakout is seen in these stocks; do you hold them?

Nifty 50 started lower on the back of negative global trends. In this post, we have highlighted stocks that have witnessed a solid positive breakout despite weak trends.

Henil Shah Article rating: 4.1

Are you looking for stocks to trade today? Check out this article that lists stocks experiencing a solid positive breakout despite weakness in the markets.

A strong positive breakout is seen in these stocks; do you hold them?
A strong positive breakout is seen in these stocks; do you hold them?

A strong positive breakout is seen in these stocks; do you hold them?

Nifty 50 opened the week on a sombre note due to poor global trends. In this post, we have highlighted stocks that are experiencing a strong positive breakout.

Henil Shah Article rating: 4.1

Nifty 50 opened the week on a sombre note due to poor global trends. In this post, we have highlighted stocks that are experiencing a strong positive breakout.

Max Healthcare Institute acquires stake in Eqova Healthcare
Max Healthcare Institute acquires stake in Eqova Healthcare

Max Healthcare Institute acquires stake in Eqova Healthcare

Today it announced the deal to purchase Eqova Healthcare Private Limited, a company with long term exclusive rights to help develop and provide medical services to a 400 beds hospital to be built on 2.1 acres of land parcel in Patparganj

Kaustubh Bhosale Article rating: 5.0

Max Healthcare Institute is one of India’s largest private healthcare providers. Today it announced the deal to purchase Eqova Healthcare Private Limited, a company with long term exclusive rights to help develop and provide medical services to a 400 beds hospital to be built on 2.1 acres of land parcel in Patparganj, Delhi, which is owned by Nirogi Charitable and Medical Research Trust. 

RSS

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR